Cargando…
Comparison of 21-gene assay and St.Gallen International Expert Consensus in the treatment decision for patients with early invasive breast cancers
This study aimed to evaluate the impacts of 21-gene recurrence score (RS) and St. Gallen International Expert Consensus on treatment decision and prognosis of patients with invasive breast cancer. We retrospectively analyzed the therapy protocol and outcome of 134 cases based on age, body mass index...
Autores principales: | Luo, Ming, Li, Fu, Su, Ka, Yuan, Huiming, Zeng, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012076/ https://www.ncbi.nlm.nih.gov/pubmed/31663437 http://dx.doi.org/10.1080/15384047.2019.1669994 |
Ejemplares similares
-
St.Gallen consensus on safe implementation of transanal total mesorectal excision
por: Adamina, Michel, et al.
Publicado: (2017) -
Abstracts presented at the 14th European Colorectal Congress (#ECCStGallen), 29.11.2020–2.12.2020, St.Gallen, Switzerland
por: Adamina, Michel, et al.
Publicado: (2021) -
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
por: Goldhirsch, A., et al.
Publicado: (2009) -
Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference
por: Untch, Michael, et al.
Publicado: (2021) -
Controversial Opinion of “All pCRs are the Same” in St. Gallen International Consensus Guidelines 2021
por: Cong, Bin-Bin, et al.
Publicado: (2022)